Khedr E M, Kotb H, Kamel N F, Ahmed M A, Sadek R, Rothwell J C
Department of Neurology, Assiut University Hospital, Assiut, Egypt.
J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):833-8. doi: 10.1136/jnnp.2004.055806.
A single session of repetitive transcranial magnetic stimulation (rTMS) over motor cortex had been reported to produce short term relief of some types of chronic pain. The present study investigated whether five consecutive days of rTMS would lead to longer lasting pain relief in unilateral chronic intractable neuropathic pain.
Forty eight patients with therapy resistant chronic unilateral pain syndromes (24 each with trigeminal neuralgia (TGN) and post-stroke pain syndrome (PSP)) participated. Fourteen from each group received 10 minutes real rTMS over the hand area of motor cortex (20 Hz, 10x10 s trains, intensity 80% of motor threshold) every day for five consecutive days. The remaining patients received sham stimulation. Pain was assessed using a visual analogue scale (VAS) and the Leeds assessment of neuropathic symptoms and signs (LANSS) scale, before, after the first, fourth, and fifth sessions, and two weeks after the last session.
No significant differences were found in basal pain ratings between patients receiving real- and sham-rTMS. However, a two factor ANOVA revealed a significant "+/- TMS" x "time" interaction indicating that real and sham rTMS had different effects on the VAS and LANSS scales. Post hoc testing showed that in both groups of patients, real-rTMS led to a greater improvement in scales than sham-rTMS, evident even two weeks after the end of the treatment. No patient experienced adverse effects.
These results confirm that five daily sessions of rTMS over motor cortex can produce longlasting pain relief in patients with TGN or PSP.
据报道,单次重复经颅磁刺激(rTMS)作用于运动皮层可使某些类型的慢性疼痛得到短期缓解。本研究调查了连续五天进行rTMS是否能使单侧慢性顽固性神经性疼痛得到更持久的疼痛缓解。
48例患有治疗抵抗性慢性单侧疼痛综合征的患者(三叉神经痛(TGN)和中风后疼痛综合征(PSP)各24例)参与研究。每组14例患者连续五天每天在运动皮层手部区域接受10分钟的真实rTMS(20Hz,10×10秒串,强度为运动阈值的80%)。其余患者接受假刺激。在第一次、第四次和第五次治疗前、治疗后以及最后一次治疗后两周,使用视觉模拟量表(VAS)和利兹神经性症状和体征评估(LANSS)量表对疼痛进行评估。
接受真实rTMS和假rTMS的患者在基础疼痛评分上未发现显著差异。然而,双因素方差分析显示存在显著的“+/- TMS”ד时间”交互作用,表明真实rTMS和假rTMS对VAS和LANSS量表有不同影响。事后检验表明,在两组患者中,真实rTMS比假rTMS在量表上导致更大的改善,甚至在治疗结束两周后仍很明显。没有患者出现不良反应。
这些结果证实,每天对运动皮层进行五次rTMS治疗可使TGN或PSP患者的疼痛得到持久缓解。